CM
C Ann Merrifield

C Ann Merrifield insider trades: Lyra Therapeutics (LYRA) stock purchases

Lyra Therapeutics Last trade Jun 10, 2022 41 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2015
5
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where C reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 10, 2022LYRA↑ Buy$20K
May 16, 2022LYRA↑ Buy$18K
Jun 17, 2021LYRA↑ Buy$31K
May 23, 2019FLXN↑ Buy$101K
Aug 26, 2016JNP↑ Buy$11K
Jun 14, 2016FLXN↑ Buy$13K
Dec 4, 2015JNP↑ Buy$19K
Sep 11, 2015FLXN↑ Buy$23K
Aug 14, 2015JNP↑ Buy$30K
Aug 12, 2015NVIV↑ Buy$25K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LYRA insiders

Open-market trades in the last 12 months

About C Ann Merrifield's insider trades

C Ann Merrifield is an insider at Lyra Therapeutics (LYRA). Since Aug 12, 2015, C has reported 10 open-market purchases worth $293K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (25 filings), shares returned to the company (3 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.